| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $2,740,204 ) |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 5 | FDA | 9/11/2024 | $100,000 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 000 | 4 | FDA | 4/30/2024 | $75,000 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 002 | 5 | FDA | 9/18/2024 | $54,718 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 002 | 5 | FDA | 9/18/2024 | -$293,939 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 5 | FDA | 9/11/2024 | $100,000 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 5 | FDA | 9/11/2024 | $170,000 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 5 | FDA | 9/11/2024 | $75,000 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 5 | FDA | 9/11/2024 | $325,000 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 5 | FDA | 9/11/2024 | $110,000 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 5 | FDA | 9/11/2024 | $771,785 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 5 | FDA | 9/11/2024 | $336,800 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 5 | FDA | 9/11/2024 | $90,000 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 5 | FDA | 9/11/2024 | $140,000 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 5 | FDA | 9/11/2024 | $275,000 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 5 | FDA | 9/11/2024 | $21,619 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 5 | FDA | 9/11/2024 | $150,000 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 002 | 5 | FDA | 9/18/2024 | $25,621 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 002 | 5 | FDA | 9/18/2024 | $128,512 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 002 | 5 | FDA | 9/18/2024 | $15,832 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 002 | 5 | FDA | 9/18/2024 | $23,416 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 002 | 5 | FDA | 9/18/2024 | $37,569 |
| 2024 | 2024 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 002 | 5 | FDA | 9/18/2024 | $8,271 |
| 2024 | 2022 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1333 NEW HAMPSHIRE AVE NW STE 420 | WASHINGTON | DC | 20036-1578 | DISTRICT OF COLUMBIA | USA | U01FD007779 | Real-World Accelerator to evolve the standard of Care and Engagement in clinical studies (RACE) | 001 | 1 | FDA | 8/13/2024 | $0 |
| 2024 | 2022 | REAGAN UDALL FOUNDATION FOR THE FDA, INC. | 1333 NEW HAMPSHIRE AVE., NW | WASHINGTON | DC | 20036-1532 | DISTRICT OF COLUMBIA | USA | U01FD007779 | Real-World Accelerator to evolve the standard of Care and Engagement in clinical studies (RACE) | 000 | 1 | FDA | 1/4/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $2,653,298 ) |
| 2023 | 2023 | REAGAN UDALL FOUNDATION FOR THE FDA, INC. | 1333 NEW HAMPSHIRE AVE., NW | WASHINGTON | DC | 20036-1532 | DISTRICT OF COLUMBIA | USA | U01FD007779 | Real-World Accelerator to evolve the standard of Care and Engagement in clinical studies (RACE) | 000 | 1 | FDA | 8/1/2023 | $375,000 |
| 2023 | 2023 | REAGAN UDALL FOUNDATION FOR THE FDA, INC. | 1333 NEW HAMPSHIRE AVE., NW | WASHINGTON | DC | 20036-1532 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 4 | FDA | 9/7/2023 | $25,000 |
| 2023 | 2023 | REAGAN UDALL FOUNDATION FOR THE FDA, INC. | 1333 NEW HAMPSHIRE AVE., NW | WASHINGTON | DC | 20036-1532 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 4 | FDA | 9/7/2023 | $5,000 |
| 2023 | 2023 | REAGAN UDALL FOUNDATION FOR THE FDA, INC. | 1333 NEW HAMPSHIRE AVE., NW | WASHINGTON | DC | 20036-1532 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 4 | FDA | 9/7/2023 | $817,994 |
| 2023 | 2023 | REAGAN UDALL FOUNDATION FOR THE FDA, INC. | 1333 NEW HAMPSHIRE AVE., NW | WASHINGTON | DC | 20036-1532 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 4 | FDA | 9/7/2023 | $500,000 |
| 2023 | 2023 | REAGAN UDALL FOUNDATION FOR THE FDA, INC. | 1333 NEW HAMPSHIRE AVE., NW | WASHINGTON | DC | 20036-1532 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 4 | FDA | 9/7/2023 | $98,000 |
| 2023 | 2023 | REAGAN UDALL FOUNDATION FOR THE FDA, INC. | 1333 NEW HAMPSHIRE AVE., NW | WASHINGTON | DC | 20036-1532 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 4 | FDA | 9/7/2023 | $30,000 |
| 2023 | 2023 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1900 L ST NW STE 835 | WASHINGTON | DC | 20036-5009 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 000 | 3 | FDA | 12/23/2022 | $87,710 |
| 2023 | 2023 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1900 L ST NW STE 835 | WASHINGTON | DC | 20036-5009 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 000 | 3 | FDA | 12/23/2022 | $90,714 |
| 2023 | 2023 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1900 L ST NW STE 835 | WASHINGTON | DC | 20036-5009 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 000 | 3 | FDA | 12/23/2022 | $135,735 |
| 2023 | 2023 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1900 L ST NW STE 835 | WASHINGTON | DC | 20036-5009 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 000 | 3 | FDA | 12/23/2022 | $22,510 |
| 2023 | 2023 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1900 L ST NW STE 835 | WASHINGTON | DC | 20036-5009 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 000 | 3 | FDA | 12/23/2022 | $49,628 |
| 2023 | 2023 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1900 L ST NW STE 835 | WASHINGTON | DC | 20036-5009 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 000 | 3 | FDA | 12/23/2022 | $281,377 |
| 2023 | 2023 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1900 L ST NW STE 835 | WASHINGTON | DC | 20036-5009 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 000 | 3 | FDA | 12/23/2022 | $64,143 |
| 2023 | 2023 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1900 L ST NW STE 835 | WASHINGTON | DC | 20036-5009 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 000 | 3 | FDA | 12/23/2022 | $30,487 |
| 2023 | 2023 | REAGAN UDALL FOUNDATION FOR THE FDA, INC. | 1333 NEW HAMPSHIRE AVE., NW | WASHINGTON | DC | 20036-1532 | DISTRICT OF COLUMBIA | USA | U01FD007779 | Real-World Accelerator to evolve the standard of Care and Engagement in clinical studies (RACE) | 001 | 1 | FDA | 8/15/2023 | $0 |
| 2023 | 2023 | REAGAN UDALL FOUNDATION FOR THE FDA, INC. | 1333 NEW HAMPSHIRE AVE., NW | WASHINGTON | DC | 20036-1532 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 001 | 4 | FDA | 9/7/2023 | $40,000 |
| 2023 | 2023 | REAGAN UDALL FOUNDATION FOR THE FDA, INC. | 1333 NEW HAMPSHIRE AVE., NW | WASHINGTON | DC | 20036-1532 | DISTRICT OF COLUMBIA | USA | U01FD007779 | Real-World Accelerator to evolve the standard of Care and Engagement in clinical studies (RACE) | 002 | 1 | FDA | 8/22/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $4,234,883 ) (Continued on the next page) |
| 2022 | 2022 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1900 L ST NW STE 835 | WASHINGTON | DC | 20036-5009 | DISTRICT OF COLUMBIA | USA | U01FD007779 | Real-World Accelerator to evolve the standard of Care and Engagement in clinical studies (RACE) | 000 | 1 | FDA | 8/16/2022 | $499,514 |
| 2022 | 2022 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1900 L ST NW STE 835 | WASHINGTON | DC | 20036-5009 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 004 | 3 | FDA | 9/15/2022 | $639,639 |
| 2022 | 2022 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1900 L ST NW STE 835 | WASHINGTON | DC | 20036-5009 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 004 | 3 | FDA | 9/15/2022 | $24,191 |
| 2022 | 2022 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1900 L ST NW STE 835 | WASHINGTON | DC | 20036-5009 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 004 | 3 | FDA | 9/15/2022 | $300,645 |
| 2022 | 2022 | REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION, INC. | 1900 L ST NW STE 835 | WASHINGTON | DC | 20036-5009 | DISTRICT OF COLUMBIA | USA | U01FD007223 | SPARC: Supporting Patient Access, Real-world data, and critical Collaborations | 004 | 3 | FDA | 9/15/2022 | $49,584 |
|